BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38372253)

  • 21. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
    El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM
    Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
    Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
    Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD
    Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease.
    Wang D; Hu M; Li X; Zhang D; Chen C; Fu J; Shao S; Shi G; Zhou Y; Wu S; Zhang T
    Eur J Med Chem; 2019 Apr; 168():207-220. PubMed ID: 30822710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphenylalkoxyamine Derivatives-Histamine H
    Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.
    Sinha A; Tamboli RS; Seth B; Kanhed AM; Tiwari SK; Agarwal S; Nair S; Giridhar R; Chaturvedi RK; Yadav MR
    Mol Neurobiol; 2015 Aug; 52(1):638-52. PubMed ID: 25257697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, molecular modeling and neuroprotective effects of a new framework of cholinesterase inhibitors for Alzheimer's disease.
    Zanon VS; Lima JA; Amaral RF; Lima FRS; Kitagawa DAS; França TCC; Vargas MD
    J Biomol Struct Dyn; 2021 Oct; 39(16):6112-6125. PubMed ID: 32715924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
    Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Du C; Wang L; Guan Q; Yang H; Chen T; Liu Y; Li Q; Lyu W; Lu X; Chen Y; Liu Y; Liu H; Feng F; Liu W; Liu Z; Li W; Chen Y; Sun H
    J Med Chem; 2022 Aug; 65(16):11365-11387. PubMed ID: 35969197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis,
    Mo J; Chen T; Yang H; Guo Y; Li Q; Qiao Y; Lin H; Feng F; Liu W; Chen Y; Liu Z; Sun H
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):330-343. PubMed ID: 31856607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of spatial memory in 5xFAD mice by targeting cholinesterases, oxidative stress and inflammatory signaling using 2-(hydroxyl-(2-nitrophenyl)methyl)cyclopentanone.
    Ullah R; Ali G; Subhan F; Khan A; Ahsan Halim S; Naveed M; Kalsoom S; Al-Harrasi A
    Int Immunopharmacol; 2021 Nov; 100():108083. PubMed ID: 34478946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
    Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
    Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
    Gurjar AS; Darekar MN; Yeong KY; Ooi L
    Bioorg Med Chem; 2018 May; 26(8):1511-1522. PubMed ID: 29429576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective evaluation of diospyrin against drug-induced Alzheimer's disease.
    Alam A; Ali G; Nawaz A; AlOmar TS; Rauf A; Ayaz M; Ahmad S; Almasoud N; AlOmar AS; Khalil AA; Wilairatana P
    Fitoterapia; 2023 Dec; 171():105703. PubMed ID: 37852388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.
    Zhou D; Zhou W; Song JK; Feng ZY; Yang RY; Wu S; Wang L; Liu AL; Du GH
    Acta Pharmacol Sin; 2016 Nov; 37(11):1401-1412. PubMed ID: 27498773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
    Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T
    Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.